Table 2.

Transcripts found differentially expressed across all pairwise comparisons (top) and across normal versus primary tumor and primary tumor versus metastatic samples comparisons (bottom).

Transcript	Mean fold difference
	P versus N	M versus P	M versus N
ACOT11-001	0.79	0.77	0.61
AOX1-001	0.79	0.56	0.44
C19orf46-002	1.24	1.23	1.53
C8orf84-001	0.76	0.75	0.57
COCH-202	0.76	0.83	0.63
CTA-55I10.1-001	0.83	0.68	0.56
DMD-024	0.74	0.82	0.60
FGF10-002	0.83	0.64	0.53
FGFR2-008	0.76	0.79	0.60
FGFR2-016	0.74	0.67	0.49
GABRE-006	0.79	0.83	0.66
GNAL-001	0.82	0.69	0.57
GNAO1-002	0.78	0.75	0.58
HEATR8-006	0.80	0.80	0.64
ISL1-002	0.80	0.81	0.65
NR2F2-202	0.82	0.82	0.68
PCP4-004	0.81	0.72	0.58
PDE5A-005	0.74	0.79	0.59
PDZRN4-202	0.80	0.71	0.57
RSRC2-017	1.27	1.28	1.63
TGM4-001	0.68	0.62	0.42
TSPAN2-001	0.80	0.77	0.61
ABCC4-004	1.35	0.81	N.A.
ALK-001	1.24	0.83	N.A.
ATP1A1-002	1.23	0.71	N.A.
NAMPT-006	1.34	0.73	N.A.
NAMPT-007	1.75	0.57	N.A.
RP11-627G23.1-004	1.38	0.78	N.A.

N: Normal, P: Primary and M: Metastatic samples. N.A.: not applicable.